MHRA updates warfarin safety advice

Safety issues surrounding the use of warfarin have been reviewed by the MHRA.

As detailed in the agency's Public Assessment Report, the drug's contraindications have been tightened to include use within 72 hours of surgery or 48 hours of labour.

Active peptic ulcer, risk factors for haemorrhage and thyroid disorders are listed amongst the circumstances in which use of warfarin requires caution.

The list of potential drug interactions has been updated and liver dysfunction has been added as a potential adverse effect.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

MIMS launches Respiratory and Allergy Learning workshops 2019

MIMS launches Respiratory and Allergy Learning workshops 2019

Join us for the MIMS Workshops Respiratory and Allergy...

Hormone Replacement Therapy (HRT)

Hormone Replacement Therapy (HRT)

Hormone doses and costs of HRT preparations.

Widespread false diagnosis of COPD is exposing patients to unnecessary medication risks, study suggests
Blood Glucose Testing Strips and Meters

Blood Glucose Testing Strips and Meters

Compatible test strips for blood glucose meters.